CompletedNot Applicable

BC179 Relieves Discomfort After Drinking

China60 participantsStarted 2024-07-01

Plain-language summary

To assess the effectiveness and safety of probiotic strain BC179 in reducing alcohol absorption in the gut, thereby lowering health risks.

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Participants must be aged between 18 and 65 years.
✓. They should have a documented history of long-term alcohol consumption, defined as consuming at least 20 grams of ethanol per day for at least one year. This is calculated using the formula: volume (mL) × alcohol content (%) × 0.8.
✓. They must provide written informed consent and be willing to comply with the study procedures.

✕. History of chronic liver, gastrointestinal, or systemic metabolic disorders.
✕. Use of products with similar functions to the investigational formulation within the past two weeks.
✕. Use of antibiotics, laxatives, or dietary supplements within the past four weeks.
✕. Documented history of hypertension or diabetes.
✕. Severe allergies or immune deficiencies.
✕. Pregnancy, lactation, or planning pregnancy without effective contraception during the study period.

Effects of BC179 on alcohol metabolism

Timeframe: 60 days

NCT IDNCT06899620

SponsorWecare Probiotics Co., Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-11-30